MicroRNA-494 inhibits breast cancer progression by directly targeting PAK1

被引:85
作者
Zhan, Meng-Na [1 ,2 ]
Yu, Xiao-Ting [3 ]
Tang, Jun [4 ,5 ]
Zhou, Ci-Xiang [1 ,2 ]
Wang, Chen-Long [1 ,2 ]
Yin, Qian-Qian [1 ,2 ]
Gong, Xiu-Feng [1 ,2 ]
He, Ming [1 ,2 ]
He, Jian-Rong [6 ]
Chen, Guo-Qiang [1 ,2 ,4 ,5 ]
Zhao, Qian [1 ,2 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Dept Pathophysiol, Key Lab Cell Differentiat & Apoptosis,Natl Minis, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Shanghai, Peoples R China
[3] Tongji Univ, Sch Med, Tong Ji Hosp, Dept Pathol, Shanghai, Peoples R China
[4] Shanghai Jiao Tong Univ, Sch Med, Inst Hlth Sci, Shanghai, Peoples R China
[5] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China
[6] Shanghai Jiao Tong Univ, Rui Jin Hosp, Dept Gen Surg, Sch Med, Shanghai, Peoples R China
基金
美国国家科学基金会;
关键词
EPITHELIAL-MESENCHYMAL TRANSITION; IN-VITRO; ACTIVATION; EXPRESSION; INVASION; MIR-494; PROLIFERATION; TUMORIGENESIS; PROTRUSION; HALLMARKS;
D O I
10.1038/cddis.2016.440
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
MicroRNA (miRNA) is involved in the progression and metastasis of diverse human cancers, including breast cancer, as strong evidence has been found that miRNAs can act as oncogenes or tumor suppressor genes. Here, we show that miR-494 is decreased in human breast cancer specimens and breast cancer cell lines. Ectopic expression of miR-494 in basal-like breast cancer cell lines MDA-MB-231-LUC-D2H3LN and BT-549 inhibits clonogenic ability and metastasis-relevant traits in vitro. Moreover, ectopic expression of miR-494 suppresses neoplasm initiation as well as pulmonary metastasis in vivo. Further studies have identified PAK1, as a direct target gene of miR-494, contributes to the functions of miR-494. Remarkably, the expression of PAK1 is inversely correlated with the level of miR-494 in human breast cancer samples. Furthermore, re-expression of PAK1 partially reverses miR-494-mediated proliferative and clonogenic inhibition as well as migration and invasion suppression in breast cancer cells. Taken together, these findings highlight an important role for miR-494 in the regulation of progression and metastatic potential of breast cancer and suggest a potential application of miR-494 in breast cancer treatment.
引用
收藏
页码:e2529 / e2529
页数:11
相关论文
共 47 条
[1]  
Alberts B., 2002, Molecular Biology of the Cell. (4th edition), V4th ed
[2]  
Anderson B.O., 2015, Cancer: Disease Control Priorities, V3
[3]   PAK to the future [J].
Bagrodia, S ;
Cerione, RA .
TRENDS IN CELL BIOLOGY, 1999, 9 (09) :350-355
[4]   MicroRNAs: Target Recognition and Regulatory Functions [J].
Bartel, David P. .
CELL, 2009, 136 (02) :215-233
[5]   Amplification of 11q13 in ovarian carcinoma [J].
Brown, Lindsay A. ;
Kalloger, Steve E. ;
Miller, Melinda A. ;
Shih, le-Ming ;
McKinney, Steven E. ;
Santos, Jennifer L. ;
Swenerton, Ken ;
Spellman, Paul T. ;
Gray, Joe ;
Gilks, C. Blake ;
Huntsman, David G. .
GENES CHROMOSOMES & CANCER, 2008, 47 (06) :481-489
[6]   Cofilin activity downstream of Pak1 regulates cell protrusion efficiency by organizing lamellipodium and lamella actin networks [J].
Delorme, Violaine ;
Machacek, Matthias ;
DerMardirossian, Celine ;
Anderson, Karen L. ;
Wittmann, Torsten ;
Hanein, Dorit ;
Waterman-Storer, Clare ;
Danuser, Gaudenz ;
Bokoch, Gary M. .
DEVELOPMENTAL CELL, 2007, 13 (05) :646-662
[7]   Pak1 regulates focal adhesion strength, myosin IIA distribution, and actin dynamics to optimize cell migration [J].
Delorme-Walker, Violaine D. ;
Peterson, Jeffrey R. ;
Chernoff, Jonathan ;
Waterman, Clare M. ;
Danuser, Gaudenz ;
DerMardirossian, Celine ;
Bokoch, Gary M. .
JOURNAL OF CELL BIOLOGY, 2011, 193 (07) :1289-1303
[8]   Activation of LIM-kinase by Pak1 couples Rac/Cdc42 GTPase signalling to actin cytoskeletal dynamics [J].
Edwards, DC ;
Sanders, LC ;
Bokoch, GM ;
Gill, GN .
NATURE CELL BIOLOGY, 1999, 1 (05) :253-259
[9]   PTEN: One gene, many syndromes [J].
Eng, C .
HUMAN MUTATION, 2003, 22 (03) :183-198
[10]   Genetic pathways in the evolution of breast ductal carcinoma in situ [J].
Farabegoli, F ;
Champeme, MH ;
Bieche, I ;
Santini, D ;
Ceccarelli, C ;
Derenzini, M ;
Lidereau, R .
JOURNAL OF PATHOLOGY, 2002, 196 (03) :280-286